-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Perianal fistula is a characteristic complication of Crohn's disease (CD) patients .
Perianal fistula is a characteristic complication of Crohn’s disease (CD) patients.
Perianal fistula-related cancer is an under-researched risk faced by CD patients.
diagnosis
This is a retrospective case-control study conducted in four German hospitals.
The overall survival rate of patients stratified according to histological type, lymph node metastasis, distant metastasis, and surgical margins
The overall survival rate of patients stratified according to histological type, lymph node metastasis, distant metastasis, and surgical marginsAmong 40 patients with malignant tumors, 33 cases were adenocarcinoma and 7 cases were squamous cell carcinoma.
Compared with patients with cancer-free perianal fistula CD, patients with fistula-related malignancies were younger when they were diagnosed with Crohn's disease.
Progression-free survival of patients stratified according to histological type, lymph node metastasis, distant metastasis, and surgical margins
Progression-free survival of patients stratified according to histological type, lymph node metastasis, distant metastasis, and surgical marginsThere were significant differences in fistula-related findings between the two groups.
Complex and severe fistula signs, including complex anatomy and chronic activity, are significantly more common in patients with fistula-related malignancies.
In patients with adenocarcinoma or squamous cell carcinoma with Crohn’s disease and perianal fistula, the characteristics of the fistula determine the risk of malignancy.
Original source:
Palmieri Chiara, Müller Gerhard, Kroesen Anton J et al.
org/10.
1093/ecco-jcc/jjab05" target="_blank" rel="noopener">Perianal fistula-associated carcinoma in Crohn's disease: a multicenter retrospective case control study in this message